3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
10
INDUSTRY
8
NIH
1
FED
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Prostatic Neoplasms
46
Neoplasms
36
Colorectal Neoplasms
36
Lung Neoplasms
21
Breast Neoplasms
13
Colonic Polyps
11
Colonic Neoplasms
11
Rare Diseases
9
Carcinoma, Non-Small-Cell Lung
9
Carcinoma, Hepatocellular
7
Pulmonary Disease, Chronic Obstructive
6
Neoplasm Metastasis
6
Heart Failure
6
Ovarian Neoplasms
5
Motor Activity
5
Liver Neoplasms
5
Head and Neck Neoplasms
5
Fibrosis
5
Carcinoma, Squamous Cell
5
Barrett Esophagus
5
Adenoma
5
Urinary Bladder Neoplasms
4
Neoplasms by Site
4
Mental Disorders
4
Lymphoma
4
Lung Diseases
4
Leukemia
4
Esophageal Neoplasms
4
Adenocarcinoma Of Esophagus
4
Urinary Incontinence
3
Interventions
olaparib
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
FED
×
Interventional
×
Fanconi Anemia, Complementation Group D1
×
Clear all
NCT04038502
2025-08-20
COBRA
VA Office of Research and Development
Phase 2
Recruiting
100 enrolled